Medtronic (MDT) is a publicly traded Healthcare sector company. As of May 20, 2026, MDT trades at $77.78 with a market cap of $99.27B and a P/E ratio of 21.02. MDT moved -0.65% today. Year to date, MDT is -18.19%; over the trailing twelve months it is -9.65%. Its 52-week range spans $74.40 to $106.33. Analyst consensus is buy with an average price target of $105.58. Rallies surfaces MDT's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies organizes MDT SEC filing research, company disclosures, 10-K reports, 10-Q reports, and filing-driven context alongside market data, news, fundamentals, and AI research.
| Metric | Value |
|---|---|
| Price | $77.78 |
| Market Cap | $99.27B |
| P/E Ratio | 21.02 |
| EPS | $3.72 |
| Dividend Yield | 0.71% |
| 52-Week High | $106.33 |
| 52-Week Low | $74.40 |
| Volume | 7.66M |
| Avg Volume | 0 |
| Revenue (TTM) | $34.76B |
| Net Income | $4.79B |
| Gross Margin | 65.51% |
20 analysts cover MDT: 0 strong buy, 12 buy, 8 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $105.58.